Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma
Clinical trial NCT06485739 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06485739
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.